XML 28 R11.htm IDEA: XBRL DOCUMENT  v2.3.0.11
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
 9 Months Ended
Jul. 31, 2011
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
NOTE 6 - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company utilizes derivative instruments to reduce its exposure to the effects of the variability of interest rates and foreign currencies on its financial performance when it believes such action is warranted. Historically, the Company has been a party to derivative instruments to hedge either the variability of cash flows of a prospective transaction or the fair value of a recorded asset or liability. In certain instances, the Company has designated these transactions as hedging instruments. However, whether or not a derivative was designated as being a hedging instrument, the Company's purpose for engaging in the derivative has always been for risk management and not speculative purposes. The Company historically has not been a party to a significant number of derivative instruments and does not expect its derivative activity to significantly increase in the foreseeable future.

In addition to the utilization of derivative instruments discussed above, the Company attempts to minimize its risk of foreign currency exchange rate variability by, whenever possible, procuring production materials within the same country that it will utilize the materials in manufacturing, and by selling to customers from manufacturing sites within the country in which the customers are located.

On May 15, 2009, in connection with an amendment to its credit facility, the Company issued 2.1 million warrants, each exercisable for one share of the Company's common stock at an exercise price of $0.01 per share. Forty percent of the warrants were exercisable upon issuance, and the remaining balance was to become exercisable in twenty percent increments at various points in time after October 31, 2009. As a result of certain net cash settleable put provisions within the warrant agreement, the warrants were recorded as a liability in the Company's consolidated balance sheet. As of the issuance date and for future periods that such warrants remain outstanding, the Company has, and will continue to, adjust the liability based upon the current fair value of the warrants, with any changes in their fair value being recognized in earnings. Due to the warrants' exercise price of $0.01 per share, their fair value will approximate the market price of the Company's common stock. Approximately 1.2 million of these warrants were cancelled as a result of the Company's early repayment of certain amounts under its credit facility during the year ended November 1, 2009, and the associated liability was reduced accordingly.

The table below presents the effect of derivative instruments on the Company's condensed consolidated balance sheets at July 31, 2011 and October 31, 2010.

Derivatives
         
Not Designated
         
as Hedging
       Fair Value at 
Instruments Under
       July 31,   October 31, 
ASC 815
   
Balance Sheet Location
  2011   2010 
 
                 
Warrants on common stock
   
Other liabilities
  $
1,322
   $
1,881
 

     The table below presents the effect of derivative instruments on the Company's condensed consolidated statements of income for the three and nine month periods ended July 31, 2011 and August 1, 2010.

Derivatives Not Designated
     Amount of Gain (Loss) Recognized Related to Derivative Instruments 
as Hedging
  
Location of Gain (Loss)
 Three Months Ended  Nine Months Ended 
Instruments Under
  
Related to
 July 31,  August 1,  July 31,  August 1, 
ASC 815
  
Derivative Instruments
 2011  2010  2011  2010 
 
                        
Warrants on common stock
  
Investment and other income (expense), net
 $ 
221
  $
388
  $
$(599
)  $
$(363
)